Table 1 Clinical characteristics of the hemodialysis patients
|  | DM (n = 68) | non-DM (n = 66) | P-value |
|---|---|---|---|
Age (y) | 68.7 ± 11.0 | 66.0 ± 12.8 | 0.422 |
Men/Women (n/n) | 48/20 | 35/31 | 0.037 |
HD duration (mo.) | 59.1 ± 45.5 | 111.6 ± 108.7 | < 0.001 |
Body weight (kg) | 59.0 ± 13.3 | 52.9 ± 11.1 | 0.005 |
BMI (kg/m2) | 22.8 ± 4.2 | 20.9 ± 3.8 | 0.007 |
Hb (g/dL) | 10.5 ± 1.0 | 10.5 ± 0.9 | 0.998 |
Alb (g/dL) | 3.6 ± 0.3 | 3.7 ± 0.3 | 0.245 |
Average PG (mg/dL) | 146 ± 45 | 116 ± 21 | < 0.001 |
GA (%) | 22.1 ± 4.5 | 17.8 ± 2.4 | < 0.001 |
HbA1c (%) | 6.2 ± 1.2 | 5.2 ± 0.4 | < 0.001 |
GA/HbA1c ratio | 3.56 ± 0.48 | 3.42 ± 0.49 | 0.093 |
ESA dose (µg kg/w) | 0.51 ± 0.40 | 0.54 ± 0.56 | 0.680 |
CRP (mg/dL) | 0.44 ± 0.80 | 0.31 ± 0.53 | 0.277 |
GNRI | 93.6 ± 7.0 | 92.8 ± 6.3 | 0.476 |
ChE (U/L) | 199 ± 47 | 207 ± 49 | 0.309 |
T.Chol (mg/dL) | 155 ± 38 | 157 ± 30 | 0.808 |
Cr (mg/dL) | 9.8 ± 2.4 | 10.9 ± 2.2 | 0.009 |
P (mg/dL) | 5.1 ± 1.2 | 5.4 ± 1.3 | 0.218 |
TSH (μIU/mL) | 2.2 ± 0.9 | 2.4 ± 1.9 | 0.408 |
FT4 (ng/dL) | 1.0 ± 0.2 | 1.2 ± 0.9 | 0.166 |
FT3 (pg/mL) | 1.9 ± 0.3 | 2.0 ± 0.4 | 0.245 |